Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Board Changes

24 Aug 2016 07:01

RNS Number : 9571H
Gresham Computing PLC
24 August 2016
 

24 August 2016

 

Gresham Computing plc

Board changes

Gresham Computing plc (LSE: "GHT", "Gresham" or the "Group"), the leading software and services company that specialises in providing real-time transaction control and enterprise data integrity solutions, announces the following Board changes.

The Board is pleased to announce that Imogen Joss will join the Board as Senior Independent Non-Executive Director with an effective date of 1 September 2016. Ms Joss is currently President of Platts, a division of S&P Global. She previously held executive positions at the London Stock Exchange Information Services business and senior posts in other leading data vendor companies, including Financial Times Information, Extel Financial Ltd, and Reuters plc.

Max Royde, currently Senior Non-Executive Director and chair of the Remuneration Committee, will remain on the Board as a Non-Executive Director until 30 September 2016, following which he will step down, and Ken Archer, Non-Executive Chairman, will become chair of the Remuneration Committee.

The Board wishes to recognise and thank Mr Royde for the enormous contribution that he has made to the transformation of the Group since his appointment in August 2009.

Ken Archer, Chairman, commented:

"I am delighted to welcome Imogen to the Board as Senior Independent Non-Executive Director. Imogen has a strong background in the financial services industry, and brings significant experience of building global organizations, both in Europe and the US. I would also like to thank Max for the important contribution he has made to the Group's transformation over the last 7 years. I have enjoyed working with him and the Board has valued his insight and advice."

Regulatory disclosures

Imogen Melissa Joss, aged 54, is not currently and has not at any time in the previous five years been a director of any other publicly quoted company. There is no further information required to be disclosed pursuant to Listing Rule 9.6.13 R in relation to Ms Joss.

 

Enquiries

Gresham Computing plc

Ken Archer +44 (0) 207 653 0200

Ian Manocha

Rob Grubb

N+1 Singer (Broker)

Nic Hellyer +44 (0) 207 496 3000

Lauren Kettle

 

Note to editors

Gresham's award-winning Clareti software platform has been designed to provide financial institutions with complete certainty in their data processing. Clareti is a highly flexible and fully scalable platform for assuring enterprise data integrity and is designed to address today's most challenging financial control, internal risk management, data governance and regulatory compliance problems. Gresham's portfolio of applications based on the Clareti platform, including Clareti Transaction Control (CTC) and Clareti Accounts Receivable Management (Clareti ARM), provide innovative industry and domain specific solutions for real-time data management based on business-driven controls.

Gresham Computing plc is a leading software and services company that specialises in providing real-time transaction control and enterprise data integrity solutions. Listed on the main market of the London Stock Exchange (GHT.L) and headquartered in the City of London, customers include some of the world's largest financial institutions, all of whom are served locally from offices located in Europe, North America and Asia Pacific.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPJMRTMBJTBBF
Date   Source Headline
6th Mar 20154:38 pmRNSHolding(s) in Company
5th Mar 20157:00 amRNSDirectorate Change
26th Feb 201512:18 pmRNSHolding(s) in Company
24th Feb 201512:45 pmRNSResult of EGM
11th Feb 20152:04 pmRNSDirector Declaration
10th Feb 20157:00 amRNSCTC Contract Win
27th Jan 20157:02 amRNSDirectorate Change
27th Jan 20157:01 amRNSCancellation of Share Premium Acct. & Notice of GM
27th Jan 20157:01 amRNSTrading Update
29th Dec 20147:00 amRNSCTC Contract Win
10th Dec 20147:00 amRNSCTC Contract Win
21st Nov 20147:00 amRNSCTC Contract Extension
13th Nov 20147:00 amRNSCTC Contract Wins
4th Nov 20147:00 amRNSCTC Contract Win
3rd Nov 20145:04 pmRNSHolding(s) in Company
13th Oct 20145:14 pmRNSHolding(s) in Company
10th Oct 201412:52 pmRNSDirector/PDMR Shareholding
10th Oct 20147:00 amRNSDirector/PDMR Shareholding
9th Oct 20147:00 amRNSInterim Management Statement
2nd Sep 20147:00 amRNSDirector/PDMR Shareholding
26th Aug 20144:00 pmRNSDirector/PDMR Shareholding
14th Aug 20147:00 amRNSDirector/PDMR Shareholding
13th Aug 201411:23 amRNSDirector/PDMR Shareholding
11th Aug 20147:00 amRNSHalf Yearly Report
1st Jul 20142:34 pmRNSDirector/PDMR Shareholding
23rd Jun 20143:13 pmRNSDirector/PDMR Shareholding
23rd Jun 20147:00 amRNSDirector/PDMR Shareholding
19th Jun 20142:32 pmRNSDirector/PDMR Shareholding
19th Jun 20147:00 amRNSDirectorate Change
16th Jun 20142:44 pmRNSDirector/PDMR Shareholding
13th Jun 20147:00 amRNSDirector/PDMR Shareholding
21st May 20144:17 pmRNSDirector's Dealing
20th May 20147:00 amRNSDirector/PDMR Shareholding
19th May 20147:00 amRNSInterim Management Statement
15th May 20147:00 amRNSDirector/PDMR Shareholding
13th May 20147:00 amRNSIssue of Equity
8th May 20147:00 amRNSCTC contract win
7th May 20141:08 pmRNSResult of AGM
24th Apr 201411:13 amRNSDirector/PDMR Shareholding
22nd Apr 20147:01 amRNSDirector/PDMR Shareholding
31st Mar 20147:00 amRNSNotice of AGM
27th Mar 201412:55 pmRNSHolding(s) in Company
26th Mar 20149:41 amRNSIssue of Equity & Directors' Dealings
21st Mar 20147:00 amRNSCompany Secretary Change
19th Mar 20147:00 amRNSAnnual Financial Report
20th Feb 20144:41 pmRNSHolding(s) in Company
6th Feb 20144:33 pmRNSIssue of Equity
4th Feb 20147:00 amRNSTrading Update
6th Jan 201411:49 amRNSHolding(s) in Company
10th Dec 20135:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.